Anbogen Therapeutics, or ABT, operates as a clinical stage biopharmaceutical company that was established in 2019. Its primary focus lies in the exploration and advancement of precision medicine within the field of oncology. The company, founded by a team of outstanding scientists hailing from the esteemed National Health Research Institute in Taiwan, is committed to narrowing the gap between research and clinical development. Additionally, Anbogen Therapeutics is dedicated to pioneering breakthrough science aimed at significantly improving the lives of patients.
Anbogen Therapeutics
Headquarters
Taiwan